Sage Journals: Discover world-class research

Open access

Research article

First published 2018

Analisi di budget impact del biosimilare di etanercept: lo scenario italiano

Roberto Ravasio, Giampiero Girolomoni, Roberto Gorla

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Research article

First published 2024-5

Efficacy of switching from originator etanercept to biosimilar YLB113 in real-world patients with rheumatoid arthritis: A retrospective 12 months follow-up study

Hideo Sakane, Yukio Yonemoto, Koichi Okamura [...]

Journal of Orthopaedic Surgery

Open access

Research article

First published 2020

Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc,an etanercept biosimilar,in patients with ankylosing spondylitis: a prospective,randomized,open-label,multicentric study

Ting Zhang, Jianing Zhu, Dongyi He [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2017

Impatto Economico Dei Biosimilari in Italia: Passato,Presente e Futuro di Infliximab ed Etanercept

Andrea Marcellusi, Luca Bianchi, Antonio Gasbarrini [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Research article

First published 2022

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases

Uta Kiltz, Styliani Tsiami, Xenofon Baraliakos [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2017-11

Clinical Experience with Two Etanercept Biosimilars in Indian Patients with Spondyloarthritis

Ashok Kumar, Anshul Goel, Mehul Lapsiwala [...]

Indian Journal of Rheumatology

Retricted access

Research article

First published 2022-3

In Preparation for Biosimilar “Switch” Policy: How to Mitigate the Nocebo Effect

Kathleen D’Aguanno, Anastasiya Muntyanu, Lydia Ouchene [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2019

The economic impact of biosimilars in Italy: a scenario analysis

Francesco S Mennini, Andrea Marcellusi, Chiara Bini [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Retricted access

Review article

First published 2022-04

Current Knowledge of Biologics in Treatment of Noninfectious Uveitis

Simple Gupta, K. Shyamsundar, Mohini Agrawal [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2018-5

Of patents and patent disputes – The TNF α patent files. Part 2: Enbrel,Remicade,Cimzia and Simponi

Ulrich Storz

Human Antibodies

Search results